Simultaneous high-performance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urine.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Chromatography A

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(00)84790-8PMID 6668312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.

  1983cited by this paper
• Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.

  1982cited by this paper
• Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

  1981cited by this paper
• Properties of a new class of gastric acid inhibitors.

  1979cited by this paper
• Characterization of gastric mucosal membranes. X. Immunological studies of gastric (H+ + K+)-ATPase

  1979cited by this paper
• Gastric adenosine triphosphatases: a review of their possible role in HCl secretion.

  1977cited by this paper

• Validation of a bupropion, dextromethorphan, and omeprazole cocktail for simultaneous phenotyping of cytochrome P450 2B11, 2D15, and 3A12 activities in dogs.

  2024cites this paper
• Different Chromatographic and Electrophoretic Methods for Analysis of Proton Pump Inhibitors (PPIs): A Review

  2015cites this paper
• OPTIMIZATION AND VALIDATION OF HPLC-UV METHOD FOR SIMULTANEOUS DETERMINATION OF OMEPRAZOLE AND ITS METABOLITES IN HUMAN PLASMA: EFFECTS OF VARIOUS EXPERIMENTAL CONDITIONS AND PARAMETERS

  2011cites this paper
• Electrochemical Redox Behavior of Omeprazole Using a Glassy Carbon Electrode

  2010cites this paper
• Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.

  2010cites this paper
• Chapter 4 – Omeprazole

  2010cites this paper
• A Simple RP-HPLC Method for the Determination of Omeprazole in Human Serum and Urine: Validation and Application in Pharmacokinetic Study

  2010cites this paper
• Overview of 50 years' progress in upper gastrointestinal diseases

  2009cites this paper
• Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.

  2009cites this paper
• Bioequivalence and Pharmacokinetic Study of Two Different Omeprazole Capsule Formulations in Healthy Bangladeshi Volunteers

  2009cites this paper
• Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.

  2009cites this paper
• The effect of proton pump inhibitors (PPIs) on the orientation of Helicobacter pylori in the gastric mucus of the Mongolian gerbil in vivo .

  2008cites this paper
• Analytical methodologies for the determination of omeprazole: an overview.

  2007cites this paper
• Rapid determination of omeprazole in human plasma by protein precipitation and liquid chromatography-tandem mass spectrometry.

  2007cites this paper
• HPLC Determination of Omeprazole in Human Plasma Using a Monolithic Column

  2006cites this paper
• MEDICINAL PLANTS AND HERBS OF NEWFOUNDLAND. PART 1. CHEMICAL CONSTITUENTS OF THE AERIAL PART OF PINEAPPLE WEED (MATRICARIA MATRICARIOIDES)

  2004cites this paper
• Propranolol steady-state pharmacokinetics are unaltered by omeprazole

  2004cites this paper
• RELATIVE BIOAVAILABILITY OF OMEPRAZOLE CAPSULES AFTER ORAL DOSING

  2004cites this paper
• Improved high performance liquid chromatographic analysis of omeprazole in human plasma.

  2001cites this paper
• A RAPID HPLC-DAD METHOD FOR SEPARATION AND DETERMINATION OF OMEPRAZOLE EXTRACTED FROM HUMAN PLASMA

  2001cites this paper
• Omeprazole determination using HPLC with coulometric detection.

  2001cites this paper
• Short communication Anticonvulsant activity of omeprazole in rats

  2001cites this paper
• Anticonvulsant activity of omeprazole in rats.

  2001cites this paper
• Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction.

  1999cites this paper
• A simple high performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluid.

  1998cites this paper
• Determination of omeprazole in human plasma by high-performance liquid chromatography.

  1997cites this paper
• Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.

  1996cites this paper
• Determination of omeprazole in rat plasma by HPLC with column switching

  1994cites this paper
• Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole.

  1994cites this paper
• Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.

  1993cites this paper
• Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column.

  1992cites this paper
• Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole

  1991cites this paper
• Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

  1991cites this paper
• Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part I)

  1990cites this paper
• Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography.

  1988cites this paper
• NATURE OF THE GASTRIC ACID‐GASTRIN FEEDBACK LOOP IN THE FETAL SHEEP

  1987cites this paper
• Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

  1986cites this paper
• Fully automated gradient elution liquid chromatographic assay of omeprazole and two metabolites.

  1986cites this paper
• Placental transfer of omeprazole in maternal and fetal sheep.

  1986cites this paper
• Effect of Omeprazole on Gastric Emptying in Patients with a History of Duodenal Ulceration

  1986cites this paper
• Inhibition of human liver cytochrome P-450 by omeprazole.

  1986cites this paper
• Omeprazole inhibits oxidative drug metabolism

  1985cites this paper
• Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage.

  1985cites this paper
• Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

  1985cites this paper
• Effect of hypoxia on oxidative and reductive pathways of omeprazole metabolism by the isolated perfused rat liver.

  1985cites this paper
• The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease.

  1984cites this paper
• Effect of omeprazole and polyethylene glycol−400 on antipyrine elimination by the isolated perfused rat liver

  1984cites this paper
• Determination of omeprazole and metabolites in plasma and urine by liquid chromatography.

  1984cites this paper